8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin

Figure 3 8-bromo-7-methoxychrysin inhibition of liver cancer stem cells. 8-bromo-7-methoxychrysin (BrMC) inhibited epithelial-mesenchymal transition (EMT, A and B) and invasion (C and D) of liver cancer stem cells derived from the MHCC97 cell line (mean ± SD, n = 3). Cell morphological changes associated with EMT are shown as the phase contrast image (200 × magnification). ^aP < 0.05 vs unsorted MHCC97 cells treated with corresponding concentrations of BrMC, ^cP < 0.05 vs corresponding 0.1% DMSO treated group.